🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current study is a multicentre, randomized,double-blind, prospective cl...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2014-05
Trial ID
NCT02062489
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and tolerability ...
Status
Not Yet Recruiting
Location
UOC Fibrosi Cistica - AOUI Verona
Start Date
2026-01-15
Trial ID
NCT07289035
Treatments Being Tested
This is a biomedical and prospective study of interventional type. The tria...
Status
Completed
Location
Centre Val d'Aurelle - Paul Lamarque
Start Date
2012-06-27
Trial ID
NCT01612871
Treatments Being Tested
This is a biomedical study of interventional type, multicenter, inter-regio...
Status
Completed
Location
Clinique Calabet
Start Date
2010-06-17
Trial ID
NCT01127295
Treatments Being Tested
This is an open label phase II clinical trial to determine the efficacy, to...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2017-04-24
Trial ID
NCT02988986
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2008-06-18
Trial ID
NCT00764322
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01821066
Treatments Being Tested
This Phase III, randomized, open-label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2022-08-03
Trial ID
NCT05306340
Treatments Being Tested